Viewing Study NCT07129161


Ignite Creation Date: 2025-12-24 @ 11:53 AM
Ignite Modification Date: 2026-01-11 @ 8:40 AM
Study NCT ID: NCT07129161
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-08-19
First Post: 2025-07-24
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Iparomlimab and Tuvonralimab Combined With 2 or 4 Cycles of Chemotherapy as Neoadjuvant Therapy for Resectable NSCLC
Sponsor: Sun Yat-sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module